0001136261-22-000019.txt : 20220106
0001136261-22-000019.hdr.sgml : 20220106
20220106200426
ACCESSION NUMBER: 0001136261-22-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220105
FILED AS OF DATE: 20220106
DATE AS OF CHANGE: 20220106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DALESANDRO MARGARET
CENTRAL INDEX KEY: 0001208853
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22245
FILM NUMBER: 22516232
MAIL ADDRESS:
STREET 1: ONCOSEC MEDICAL INCORPORATED
STREET 2: 24 NORTH MAIN STREET
CITY: PENNINGTON
STATE: NJ
ZIP: 08534
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEELOS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001017491
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870449967
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVENUE
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (646) 293-2100
MAIL ADDRESS:
STREET 1: 300 PARK AVENUE
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: APRICUS BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20100914
FORMER COMPANY:
FORMER CONFORMED NAME: NEXMED INC
DATE OF NAME CHANGE: 19970311
4
1
ownership.xml
X0306
4
2022-01-05
0
0001017491
SEELOS THERAPEUTICS, INC.
SEEL
0001208853
DALESANDRO MARGARET
C/O SEELOS THERAPEUTICS, INC.
300 PARK AVENUE, 2ND FLOOR
NEW YORK
NY
10022
1
0
0
0
Stock Option (right to buy)
1.56
2022-01-05
4
A
0
35000
0.00
A
2032-01-05
Common Stock
35000
35000
D
1/12th of the shares subject to the option shall vest on February 5, 2022, and 1/12th of the shares subject to the option shall vest monthly thereafter.
/s/ Raj Mehra, as attorney-in-fact for Margaret Dalesandro
2022-01-06